FINE, a novel laboratory-based frailty index for elderly patients: a retrospective descriptive study
Keywords:
Frailty, Biomarkers, Elderly, Geriatric assessment, FINE score, Clinical frailty scale, Primary careAbstract
BACKGROUND: Frailty in older adults is a multifactorial geriatric syndrome associated with inflammation, malnutrition, and hematological decline. Objective and easily applicable laboratory-based indices may complement clinical frailty assessment by providing rapid and low-cost screening tools, particularly in primary care and resource-limited settings.
OBJECTIVES: To develop a simple laboratory-based frailty screening index (FINE, Frailty Index for the Elderly) using C-reactive protein (CRP), albumin, hemoglobin, and sex, and to evaluate its association with the Clinical Frailty Scale (CFS) in older adults.
DESIGN AND SETTING: A retrospective descriptive study conducted using electronic health records of individuals aged 80 years and older.
METHODS: Data from 322 older adults were analyzed. Their FINE scores were calculated by assigning 0 or 1 point to CRP, albumin, hemoglobin, and sex based on clinically accepted reference thresholds, yielding a total score ranging from 0 to 4. Frailty was assessed using pre-recorded CFS scores. Associations between FINE scores, CFS, and individual biomarkers were examined. The screening performance was evaluated using receiver operating characteristic (ROC) curve analysis.
RESULTS: The mean age of participants was 84.9 ± 4.0 years, and 55.6% were female. The prevalence rate of frailty was 46.6%. FINE scores exhibited a positive correlation with CFS and CRP levels, and a negative correlation with albumin and hemoglobin levels (p < 0.005). ROC analysis demonstrated a statistically significant but moderate discriminatory ability for frailty (area under the curve = 0.642; 95% confidence interval: 0.582–0.703). At a cut-off value of ≥ 0.5, FINE scores demonstrated high sensitivity (89.3%) but low specificity (22.1%).
CONCLUSION: The FINE score is a simple, rapid, and low-cost laboratory-based frailty screening tool that is significantly associated with clinical frailty and key biological processes underlying frailty. Although low specificity limits its use as a diagnostic instrument, it may serve as a practical first-step screening approach in primary care and resource-limited settings. Further multicenter prospective studies are required to validate these findings.
Downloads
References
Dent E, Morley JE, Cruz-Jentoft AJ, et al. Physical frailty: ICFSR International Clinical Practice Guidelines for Identification and Management. J Nutr Health Aging. 2019;23(9):771–87. PMID: 31641726; https://doi.org/10.1007/s12603-019-1273-z.
Clegg A, Young J, Iliffe S, Rikkert MO, Rockwood K. Frailty in elderly people. Lancet. 2013 Mar 2;381(9868):752–62. Erratum in: Lancet. 2013 Oct 19;382(9901):1328. PMID: 23395245; https://doi.org/10.1016/S0140-6736(12)62167-9.
Rockwood K, Theou O. Using the Clinical Frailty Scale in allocating scarce health care resources. Can Geriatr J. 2020 Sep 1;23(3):210–5. PMID: 32904824; https://doi.org/10.5770/cgj.23.463.
Calvani R, Marini F, Cesari M, et al.; SPRINTT consortium. Biomarkers for physical frailty and sarcopenia: state of the science and future developments. J Cachexia Sarcopenia Muscle. 2015 Dec;6(4):278–86. PMID: 26675566; https://doi.org/10.1002/jcsm.12051.
Soysal P, Stubbs B, Lucato P, et al. Inflammation and frailty in the elderly: a systematic review and meta-analysis. Ageing Res Rev. 2016 Nov;31:1–8. Erratum in: Ageing Res Rev. 2017 May;35:364-365. PMID: 27592340; https://doi.org/10.1016/j.arr.2016.12.007.
Yamamoto M, Adachi H, Enomoto M, et al. Lower albumin levels are associated with frailty measures, trace elements, and an inflammation marker in a cross-sectional study in Tanushimaru. Environ Health Prev Med. 2021 Feb 19;26(1):25. PMID: 33607942; https://doi.org/10.1186/s12199-021-00946-0.
Fritzenschaft L, Boehm F, Rothenbacher D, Denkinger M, Dallmeier D. Association of blood biomarkers with frailty-A mapping review. Ageing Res Rev. 2025 Jul;109:102761. Epub 2025 May 1. PMID: 40318768; https://doi.org/10.1016/j.arr.2025.102761.
Ofori-Asenso R, Chin KL, Mazidi M, et al. Global incidence of frailty and prefrailty among community-dwelling older adults: a systematic review and meta-analysis. JAMA Netw Open. 2019 Aug 2;2(8):e198398. PMID: 31373653; https://doi.org/10.1001/jamanetworkopen.2019.8398.
Gordon EH, Peel NM, Samanta M, Theou O, Howlett SE, Hubbard RE. Sex differences in frailty: a systematic review and meta-analysis. Exp Gerontol. 2017 Mar;89:30–40. PMID: 28043934; https://doi.org/10.1016/j.exger.2016.12.021.
Puts MTE, Toubasi S, Andrew MK, et al. Interventions to prevent or reduce the level of frailty in community-dwelling older adults: a scoping review of the literature and international policies. Age Ageing. 2017 May 1;46(3):383–92. PMID: 28064173; https://doi.org/10.1093/ageing/afw247.
Özsürekci C, Balcı C, Kızılarslanoğlu MC, et al. An important problem in an aging country: identifying the frailty via 9 Point Clinical Frailty Scale. Acta Clin Belg. 2020 Jun;75(3):200–04. PMID: 30919742; https://doi.org/10.1080/17843286.2019.1597457.
Dent E, Kowal P, Hoogendijk EO. Frailty measurement in research and clinical practice: A review. Eur J Intern Med. 2016 Jun;31:3–10. PMID: 27039014; https://doi.org/10.1016/j.ejim.2016.03.007.
Rockwood K, Song X, MacKnight C, et al. A global clinical measure of fitness and frailty in elderly people. CMAJ. 2005 Aug 30;173(5):489–95. PMID: 16129869; https://doi.org/10.1503/cmaj.050051.
Fried LP, Tangen CM, Walston J, et al; Cardiovascular Health Study Collaborative Research Group. Frailty in older adults: evidence for a phenotype. J Gerontol A Biol Sci Med Sci. 2001 Mar;56(3):M146–M156. PMID: 11253156; https://doi.org/10.1093/gerona/56.3.m146.
Marcos-Pérez D, Sánchez-Flores M, Proietti S, et al. Association of inflammatory mediators with frailty status in older adults: results from a systematic review and meta-analysis. Geroscience. 2020 Dec;42(6):1451–73. PMID: 32803650; https://doi.org/10.1007/s11357-020-00247-4.
Kuzuya M, Izawa S, Enoki H, Okada K, Iguchi A. Is serum albumin a good marker for malnutrition in the physically impaired elderly? Clin Nutr. 2007 Feb;26(1):84–90. Epub 2006 Sep 25. PMID: 16996659; https://doi.org/10.1016/j.clnu.2006.07.009.
Cabrerizo S, Cuadras D, Gomez-Busto F, Artaza-Artabe I, Marín-Ciancas F, Malafarina V. Serum albumin and health in older people: review and meta-analysis. Maturitas. 2015 May;81(1):17–27. PMID: 25782627; https://doi.org/10.1016/j.maturitas.2015.02.009.
Patel KV. Epidemiology of anemia in older adults. Semin Hematol. 2008 Oct;45(4):210–7. PMID: 18809090; https://doi.org/10.1053/j.seminhematol.2008.06.006.
Steinmeyer Z, Delpierre C, Soriano G, et al. Hemoglobin concentration; a pathway to frailty. BMC Geriatr. 2020 Jun 11;20(1):202. PMID: 32527230; https://doi.org/10.1186/s12877-020-01597-6.
Howlett SE, Rockwood MR, Mitnitski A, Rockwood K. Standard laboratory tests to identify older adults at increased risk of death. BMC Med. 2014 Oct 7;12:171. PMID: 25288274; https://doi.org/10.1186/s12916-014-0171-9.
Blodgett JM, Theou O, Howlett SE, Wu FC, Rockwood K. A frailty index based on laboratory deficits in community-dwelling men predicted their risk of adverse health outcomes. Age Ageing. 2016 Jul;45(4):463–8. PMID: 27076524; https://doi.org/10.1093/ageing/afw054.
Mailliez A, Leroy M, Génin M, et al. Development and validation of a biological frailty score based on CRP, haemoglobin, albumin and vitamin D within an electronic health record database in France: a cross-sectional study. BMJ Public Health. 2025 Mar 23;3(1):e001941. Erratum in: BMJ Public Health. 2025 Jul 31;3(2):e001941corr1. PMID: 40134541; https://doi.org/10.1136/bmjph-2024-001941corr1.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 São Paulo Medical Journal
This work is licensed under a Creative Commons Attribution 4.0 International License.
